DK
Douglas Kerr sold $44K of DYN stock
Douglas Kerr, Head of R&D and CMO of Dyne Therapeutics, Inc. (DYN), sold 2,604 shares of DYN stock worth $44K, per an SEC Form 4 filed Nov 16, 2026.
The sale was pre-arranged (a 10b5-1 plan or an option exercise), not a fresh decision.
The trade happened on Nov 13, 2026, 3 days before it was made public.
DYN has moved -9.7% since the trade date, from $17.16 to $15.50 (Nov 20, 2026 close).
- Traded
- Nov 13, 2026
- Disclosed
- Nov 16, 2026
- Filing delay
- 3 days
- Price since
- -9.7%
- Role
- Head of R&D and CMO
- Source
- SEC Form 4